Trusted Press Release Distribution   Plans | Login    

Briefing Search


Author Details
Pareesh Phulkar

Bookmark and Share
Specialty Medical Chairs Market Competitive Intelligence and Tracking Report Till 2026
Advancements in technology in specialty medical chairs is expected to support growth of the specialty medical chairs market.

Specialty Medical Chairs, 9/13/2019 - Advancements in technology in specialty medical chairs is expected to support growth of the specialty medical chairs market. For instance, Dentsply Sirona, Inc. focusing on development of new products, updating existing products, and introducing advanced technology in products. In 2016, Dentsply Sirona, Inc. invested US$ 128.5 million in product innovation. Moreover, increasing prevalence of chronic disorders is also expected to boost growth of the specialty chairs market. For instance, according to the Center for Disease Control and Prevention in 2016, 11.7% of adults in the U.S. were diagnosed with heart disease, thereby driving demand for cardiac chairs.

The global specialty medical chairs market size is estimated to be valued at US$ 5,086.1 Mn in 2018 and is expected to witness a robust CAGR of 6.2% during the forecast period (2017-2026).

Get PDF Brochure of This Business Report:

Rising prevalence of disability due to various factors such as increasing number of road accidents, spinal cord injuries, meningitis, and workplace injuries are expected to favor demand for wheelchairs over the forecast period. According to World Health Organization (WHO), around 10% people among the overall disabled population globally, require specialty medical chairs for their daily activities and physical movement.

As per the Centers for Disease Control and Prevention (CDC), in 2013, over 53 million people in the U.S. were suffering from some form of disability. Furthermore, the most common type of disability found was mobility disability, which was around 1 in 8 adults among all disabled cases in 2015, as stated by CDC. Moreover, CDC also that in the U.S., around 39.6 million people aged 18 years and above are suffering from some physical functioning disability and this number is expected to increase over the forecast period. According to stats published by the Council for Disability Awareness (CDA), in 2013, in the U.S., 1 in 4 children under 20 years of age are expected to be disabled before they retire, due to various factors such as excess body weight and chronic diseases such as diabetes, high blood pressure, and back pain.

Key players operating in the market include Dentsply Sirona, Danaher Corporation, Fresenius Kabi AG, A-DEC, Inc, ACTIVEAID, Inc, DentalEZ, Inc, Topcon Medical Systems, Inc., Midmark Corp., PLANMECA OY, and Hill Laboratories Company.

On the basis of region, the chronic lymphocytic leukemia therapeutics market is segmented into North America, Europe, Latin America, Asia Pacific, Middle East, and Africa. North America accounted for the largest market share in 2016 due to the presence of breakthrough pipeline drugs. For instance, the drug Acalabrutinib—manufactured by Acerta Pharma BV—is under phase 2 clinical trial for the treatment of CLL and small lymphocytic lymphoma (SLL) and the study is expected to complete in January 2019

Browse more detail information about:

FAQs | Contact Us | Terms & Conditions | Privacy Policy
© 2019 Proserve Technology, Inc.